Norris Medicines Limited SHARE PRICE [LIVE]

BSE: INE744C01029   NSE: -   SECTOR: -

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
N/A
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Norris Medicines Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

News

Frequently Asked Questions

Can I buy Norris Medicines Limited () shares?

Yes, You can buy Norris Medicines Limited () shares by opening a Demat account with Angel One.

How do I buy Norris Medicines Limited () from Angel One?

Norris Medicines Limited () share can be brought through the following modes:
  1. Direct investment: You can buy Norris Medicines Limited () shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Norris Medicines Limited () shares.

About

Today's live share price for Norris Medicines Limited is NSE: N/A, BSE: N/A with a current market capitalization of .

Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91. The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995. The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups focus and marketing strengths worldwide.

Read more